Histone H3K18 lactylation and cisplatin resistance in bladder cancer: insights from single-cell transcriptomic analysis

Abstract

The study by Li et al., “Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer”, investigated how histone lactylation contributes to cisplatin resistance in bladder cancer (BCa). Using high-resolution single-cell lineage tracing, the authors identified a distinct subpopulation of BCa cells with enhanced glycolytic metabolism that exhibited significant cisplatin resistance. Further analyses showed significant enrichment of histone H3 lysine 18 lactylation (H3K18la) at the promoter regions of the transcription factors YY1 and YBX1, which promoted their expression and facilitated the development of a drug-resistant phenotype. This study was the first to combine single-cell omics with lactylation modification mechanisms, providing new insights into strategies for overcoming cisplatin resistance in BCa. Nonetheless, potential limitations of the study should be carefully considered.

Keywords

Single-cell transcriptome technology / bladder cancer / histone lactylation / cisplatin resistance / transcription factors

References

[1] LiF,HuangY.Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer.Drug Resist Updat2024;73:101059

[2] TiroshI.Cancer cell states: Lessons from ten years of single-cell RNA-sequencing of human tumors.Cancer Cell2024;42:1497-506

[3] SahuV.Metabolism-driven chromatin dynamics: molecular principles and technological advances.Mol Cell2025;85:262-75 PMCID:PMC11750176

[4] LiB,WangJ.YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer.Cancer Lett2024;602:217197

[5] YokoyamaNN,SprowlS.A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer.Nucleic Acids Res2010;38:6375-88 PMCID:PMC2965227

[6] ZhaoL,GanYH.Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.Cell Death Dis2018;9:747 PMCID:PMC6030060

[7] ZhangX,GeX.NSUN2/YBX1 promotes the progression of breast cancer by enhancing HGH1 mRNA stability through m⁵C methylation.Breast Cancer Res2024;26:94 PMCID:PMC11155144

[8] WangX,NiuL.Engineered targeting OIP5 sensitizes bladder cancer to chemotherapy resistance via TRIP12-PPP1CB-YBX1 axis.Oncogene2024;43:2850-67

[9] GeT,JiaR.Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.Cancer Commun2022;42:1049-82 PMCID:PMC9648395

[10] CrispoF,LeporeS.Metabolic dysregulations and epigenetics: a bidirectional interplay that drives tumor progression.Cells2019;8:798 PMCID:PMC6721562